Stanford Medicine to target maternal complications and inequities with $14 million grant

The funding will go toward a center to decrease the incidence and downstream morbidities of postpartum hemorrhage.

A $14 million grant from the National Institutes of Health will allow Stanford Medicine to create a center to address maternal morbidities and inequities.

The National Institutes of Health has named Stanford Medicine a Maternal Health Research Center of Excellence and awarded it $14 million for an initiative entitled PRIHSM, or Preventing Inequities in Hemorrhage-Related Severe Maternal Morbidity.

Yasser El-Sayed, MD, professor of obstetrics and gynecology, and Suzan Carmichael, PhD, professor of pediatrics and of obstetrics and gynecology at Stanford Medicine, will lead the center. Stanford Medicine is one of 10 NIH Maternal Health Research Centers of Excellence selected through a competitive, peer-review process.

The goal of PRIHSM is to reduce the incidence and downstream morbidities of postpartum hemorrhage by addressing iron-deficiency anemia and cesarean births. A leading cause of maternal death and severe maternal morbidity, postpartum hemorrhage disproportionately affects socially marginalized groups.

“We are committed to being leaders in reducing maternal morbidity and health inequities surrounding postpartum hemorrhage through our center’s research projects and training initiatives, and through deepening ties to our local, regional and national communities,” El-Sayed said.

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit

2024 ISSUE 1

Psychiatry’s new frontiers